Activist investor Starboard Value is preparing a proxy fight at Autodesk Inc. (NASDAQ: ADSK), holding a stake worth over $500 million, according to the Wall Street Journal. The hedge fund plans to nominate new directors at Autodesk’s upcoming annual meeting, citing concerns over underperformance and governance issues.
Starboard argues that Autodesk has lagged behind the broader software market and is pushing for margin improvements and a board shakeup, including a reassessment of CEO Andrew Anagnost. The hedge fund previously attempted to block an Autodesk board meeting and accused the company of misleading investors regarding an accounting probe—though the investigation resulted in no financial restatements.
Autodesk shares have dropped nearly 12% in 2025, following a global restructuring plan that includes cutting 9% of its workforce. The stock also struggled through 2024, as the company delayed its annual financial reports and faced scrutiny over its accounting practices.
With Starboard’s history of activist campaigns, its latest move signals increasing pressure on Autodesk to improve financial performance and restore investor confidence.


Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Apple Turns 50: From Garage Startup to AI Crossroads
First Western Ship Transits Strait of Hormuz Since Iran War Began
Britain Courts Anthropic Amid US Defense Department Dispute
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO 



